Post date February 5, 2024 Experience Immunocore Holdings $402.5 million convertible notes offering The 2.5% convertible notes are due 2030
Post date January 11, 2024 Experience Roche $295 million acquisition of LumiraDx's point of care technology platform We are advising Roche on the acquisition
Post date January 2, 2024 Experience Myers Industries $350 million acquisition of Signature Systems We are advising Myers Industries on the acquisition
Post date December 15, 2023 Experience Atairos investment in V Sports We are advising Atairos on the minority investment
Post date December 5, 2023 Experience Cubic Telecom €473 million strategic investment by SoftBank We are advising Cubic Telecom on the strategic investment
Post date November 16, 2023 Experience Province of British Columbia $2 billion global bond offering The investment-grade bonds are due 2028
Post date November 10, 2023 Experience WeWork chapter 11 filing We are advising an ad hoc group of secured noteholders in connection with WeWork’s restructuring
Post date October 12, 2023 Experience MSCI acquisition of Trove Research We are advising MSCI on the acquisition
Post date September 18, 2023 Experience McDermott International transaction support agreement and $475 million financing We are advising an ad hoc group of crossover lenders in connection with the TSA and financing
Post date September 14, 2023 Experience Arm $4.87 billion IPO The deal is the largest U.S. IPO since November 2021